(Q40821371)

24 September 2017

1 reference

title

Hypertension-related renal injury: a major contributor to end-stage renal disease (English)

1 reference

24 September 2017

Walker WG

1

1 reference

24 September 2017

publication date

1 July 1993

1 reference

American Journal of Kidney Diseases

24 September 2017

published in

1 reference

24 September 2017

volume

22

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

164-173

1 reference

Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Renal insufficiency in treated essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Prospective study of the impact of hypertension upon kidney function in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Hemodynamic theory of progressive renal disease: a 10-year update in brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Abnormally Increased Glomerular Filtration Rate in Short-term Insulin-treated Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Increased kidney size and glomerular filtration rate in early juvenile diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Subpressor angiotensin infusion, renal sodium handling, and salt-induced hypertension in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Central role of sodium in hypertension in diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Effect of angiotensin II blockade on dietary protein-induced renal growth

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Lipoprotein(a) in diabetic patients with and without chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Prevention of phosphate-induced progression of uremia in rats by 3-phosphocitric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Calcium and phosphorus in chronic renal failure during nutritional therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Renal injury from angiotensin II-mediated hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

Pharmacology of smooth muscle cell replication

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970183-X

7 January 2021

10.1016/S0272-6386(12)70183-X

Identifiers

DOI

1 reference

24 September 2017

1 reference